Summary

Healthcare 3D Printing market to surpass USD 13336.5 million by 2030 from USD 1755.5 million in 2020 at a CAGR of 22.48% in the coming years, i.e., 2021-30.

Product Overview
Healthcare 3D printing, also known as bioprinting, was formerly thought to be a distant dream. Nonetheless, advances in technology and long-term investments have made it a reality. Currently, 3D printers are assisting pharmaceutical companies in developing more precise drugs, enabling the rapid creation of medical implants, and altering the way surgeons and doctors plan surgical procedures. Organ replacement for human patients is one of the most obvious uses of healthcare 3D printing, but it is far from the only one. Additive manufacturing is another application of 3D printing in healthcare that is gaining traction.

Market Highlights
Healthcare 3D Printing market is expected to project a notable CAGR of 22.48% in 2030
Healthcare 3D printing refers to a wide range of 3D printing items and services used in the healthcare industry. While 3D printing has grown in popularity in the manufacturing industry, it has also seen widespread adoption in the healthcare industry, with new applications emerging. The growing need for patient-specific implants in orthopedic, dentistry and other types of procedures is one of the major reasons contributing to this. Furthermore, higher productivity and manufacturing accuracy are two additional reasons driving market expansion.



Recent highlights in the Healthcare 3D Printing Market
In January 2021, Proxera, a dental additive manufacturing expert, has been purchased by ZARE, an Italian 3D printing service bureau. The deal was made to help ZARE enter into the sector. While ZARE is closely associated with Sandvik, a worldwide engineering business headquartered in Sweden, the acquisition was also intended to capitalize on Proxera's technologies on a global scale.

In August 2020, Varian Medical Technologies, Inc. was bought by Siemens Healthineers for nearly US$ 16.4 million. The purchase was made with the goal of merging the 3D printing assets of several firms while also bolstering the company's overall market presence.

Healthcare 3D Printing Market: Segments
Syringe based segment to grow with the highest CAGR during 2020-30
Healthcare 3D Printing market is segmented by Product into Syringe based, Magnetic levitation, Laser-based and Inkjet based. Among these the Syringe-based segment dominated the market in 2020, accounting for the bulk of market share. The widespread usage of 3D printers in the fields of bioprinting, food printing, and embedded printing is one of the major drivers affecting market demand. Because the technology is still in its early stages of adoption, demand is expected to rise in the future years as a wider audience in the healthcare industry embraces 3D printing.

Medical segment to grow with the highest CAGR during 2020-30
Healthcare 3D Printing market is segmented by Application into Biosensors, Medical, and Dental. Among these, the medical category will witness the highest revenue share during the forecast. Surgical implants, tissue scaffold printing, and cell printing are all examples of medical applications. These are some of the most important technological benefits of healthcare 3D printing, which will help the sector grow.

Market Dynamics
Drivers
Increasing adoption of 3D technologies
The healthcare 3D printing industry will experience exponential development as 3D printing technologies become more widely adopted. The need for 3D technologies among fracture patients, cancer patients, and skull-based tumors will propel the healthcare 3D printing industry to grow.

Increasing R&D activities
The expansion of the healthcare 3D printing industry is mostly due to research and development efforts. The companies in the healthcare 3D printing market put a lot of money into these efforts in order to create new technologies and formulas and boost their revenues. All of these factors eventually contribute to the healthcare 3D printing market's increased growth rate.

Restraint
Strict Regulation
The use of healthcare 3D printing represents a major shift in design and manufacturing technology. To extend the use of such technologies, well-trained engineers and technicians are required. Many new technologies have surpassed the capacity of the larger manufacturing workforce to adapt, and some companies have begun to struggle to find qualified workers. The influence on innovation, growth, output, and quality is substantial. The growing need for skilled labor, on the other hand, is not being fulfilled. As a result, the industry's skill shortage is well-known.

Healthcare 3D Printing Market: Key Players
Renishaw Plc

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Bio-Rad Laboratories
3D Systems Inc.
Simbionix
RegenHU Ltd.
Metamason
Stratasys Ltd.
Nano3D Biosciences Inc.
Healthcare 3D Printing Market: Regions
Healthcare 3D Printing market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific and the Middle East, and Africa. Healthcare 3D Printing market in North America held the largest market share in the year 2020. In the forecast period, the Healthcare 3D Printing market is expected to be dominated by North America. The industrial demand is primarily driven by increased regulatory support for improving quality control methods and simplifying the integration of 3D printing and traditional technologies. Additionally, institutions and manufacturers in North America have observed a higher intensity of research and development activities.



Healthcare 3D Printing Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – China, Japan, Australia, and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Healthcare 3D Printing Market report also contains analysis on:
Healthcare 3D Printing Market Segments:
By Product
Syringe based
Magnetic levitation
Laser-based
Inkjet based
By Technology
Fused deposition modeling (FDM)
Selective laser sintering (SLS)
Stereolithography
Others
By Application
Biosensors
Medical
Pharmaceuticals
Prosthetics and implants
Tissue and organ generation
Dental
Healthcare 3D Printing Market Dynamics
Healthcare 3D Printing Market Size
Supply & Demand
Current Market Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints


Healthcare 3D Printing Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2021 USD 2147.9 million
Revenue forecast in 2030 USD 13336.5 million
Growth Rate CAGR of 22.48% from 2021 to 2030
Base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2030
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product, Technology, Application and Region
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
Key companies profiled Renishaw Plc, Bio-Rad Laboratories, 3D Systems Inc., Simbionix, RegenHU Ltd., Metamason, Stratasys Ltd., Nano3D Biosciences Inc. and Other Prominent Players.


Frequently Asked Questions
How big is the Healthcare 3D Printing market?
What is the Healthcare 3D Printing market growth?
Which segment accounted for the largest Healthcare 3D Printing market share?
Who are the key players in the Healthcare 3D Printing market?
What are the factors driving the Healthcare 3D Printing market?

ページTOPに戻る

Table of Contents

Contents
1. Executive Summary
2. Healthcare 3D Printing Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Healthcare 3D Printing Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Healthcare 3D Printing Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Healthcare 3D Printing Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Latin America: (Brazil, Mexico, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Syringe based, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Magnetic levitation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Laser-based, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Inkjet based, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Technology: Market Share (2020-2030F)
12.3.1. Fused deposition modelling (FDM), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Selective laser sintering (SLS), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Stereolithography, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Applications: Market Share (2020-2030F)
12.4.1. Biosensors, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Medical, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Dental, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. Company Profile
13.1. Renishaw Plc
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Bio-Rad Laboratories
13.3. 3D Systems Inc.
13.4. Simbionix
13.5. RegenHU Ltd.
13.6. Metamason
13.7. Stratasys Ltd.
13.8. Nano3D Biosciences Inc.
Consultant Recommendation
**The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.